Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
5-Fluorouracil, folinic acid, epidoxorubicin and cisplatin (FLEP) combination chemotherapy in advanced measurable gastric cancer. A phase II trial of the Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD).
Cervantes A, Villar-Grimalt A, Abad A, Antón-Torres A, Belón J, Dorta J, Tres A, Camps C, Fonseca E, Massutí B, et al. Cervantes A, et al. Among authors: belon j. Ann Oncol. 1993 Nov;4(9):753-7. doi: 10.1093/oxfordjournals.annonc.a058660. Ann Oncol. 1993. PMID: 8280656 Free article. Clinical Trial.
A prospective randomized trial of continuous infusion 5-fluorouracil (5-FU) versus 5-FU plus cisplatin in patients with advanced colorectal cancer. A trial of the Spanish Cooperative Group for Digestive Tract Tumor Therapy (T.T.D.).
Díaz-Rubio E, Jimeno J, Antón A, Aranda E, Sánchez J, Massuti B, Cruz-Hernández J, Carrato A, Martin M, Belón J, et al. Díaz-Rubio E, et al. Among authors: belon j. Am J Clin Oncol. 1992 Feb;15(1):56-60. doi: 10.1097/00000421-199202000-00011. Am J Clin Oncol. 1992. PMID: 1550080 Clinical Trial.
Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society).
Villar-Grimalt A, Aranda E, Massutí B, Belón J, Antón A, Jimeno JM, Candel MT, García de Paredes ML, Colajori E. Villar-Grimalt A, et al. Among authors: belon j. Tumori. 1994 Apr 30;80(2):124-7. doi: 10.1177/030089169408000207. Tumori. 1994. PMID: 8016902 Clinical Trial.
Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. The ONCOPAZ Cooperative Group.
Feliu J, López Alvarez MP, Jaraiz MA, Constenla M, Vicent JM, Belón J, López Gómez L, de Castro J, Dorta J, González Barón M. Feliu J, et al. Among authors: belon j. Cancer. 2000 Oct 15;89(8):1706-13. doi: 10.1002/1097-0142(20001015)89:8<1706::aid-cncr9>3.0.co;2-i. Cancer. 2000. PMID: 11042564 Clinical Trial.
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H. Hitt R, et al. Among authors: belon j. J Clin Oncol. 2005 Dec 1;23(34):8636-45. doi: 10.1200/JCO.2004.00.1990. Epub 2005 Nov 7. J Clin Oncol. 2005. PMID: 16275937 Clinical Trial.
Phase II study of a fixed dose-rate infusion of gemcitabine associated with docetaxel in advanced non-small-cell lung carcinoma.
De Castro J, Lorenzo A, Morales S, Belón J, Dorta J, Lizón J, Madroñal C, Gallurt PM, Casado E, Feliu J, Barón MG; Oncopaz Cooperative Group. De Castro J, et al. Among authors: belon j. Cancer Chemother Pharmacol. 2005 Feb;55(2):197-202. doi: 10.1007/s00280-004-0869-z. Epub 2004 Aug 21. Cancer Chemother Pharmacol. 2005. PMID: 15322824 Clinical Trial.
A multicenter randomized Phase II trial of granulocyte-colony stimulating factor-supported, platinum-based chemotherapy with flexible midcycle cisplatin administration in patients with advanced ovarian carcinoma. PSAMOMA Cooperative Group, Spain.
Hidalgo M, Mendiola C, López-Vega JM, Castellano D, Mendez M, Batiste-Alenton E, López-Brea M, Belon J, Batista JN, Cortés-Funes H. Hidalgo M, et al. Among authors: belon j. Cancer. 1998 Aug 15;83(4):719-25. doi: 10.1002/(sici)1097-0142(19980815)83:4<719::aid-cncr13>3.0.co;2-v. Cancer. 1998. PMID: 9708936 Clinical Trial.
71 results